Pulse treatment with cadmium chloride followed by recovery caused apoptosis in U937 human promonocytic cells. In addition, the treatment-induced PKCy translocation from cytosol to membrane fraction, which was already detected at 30 min of treatment; and also caused PKCy cleavage to give a 41-kDa fragment, which was detected at 3-6 h of recovery, concomitantly with the execution of apoptosis. All these effects were reduced by the PKCy-specific inhibitor rottlerin. By contrast, rottlerin did not prevent the cadmium-provoked stimulation of the stress response (as measured by HSP70 expression), nor inhibited the generation of apoptosis by heat-shock, which failed to cause PKCy translocation. Cadmium chloride rapidly induced p38 MAPK activation, which was not affected by rottlerin. By contrast, the p38 MAPK inhibitor SB203580 reduced PKCy translocation and cleavage, indicating that p38 MAPK activation precedes and regulates PKCy activation. It is concluded that PKCy mediates apoptosis induction by cadmium ions via early membrane translocation, and also possibly through late kinase proteolytic cleavage and phosphorylation on tyrosine residues. D
Introduction
Cadmium is a widespread environmental contaminant with mutagenic, carcinogenic and teratogenic effects [1] . Exposure to this heavy metal causes both acute as well as chronic poisoning, due to its persistent accumulation in animal tissues [2] . It has been indicated that cadmium may induce apoptotic and necrotic cell death, depending on the used cell type, the used concentration, and the experimental design [3] [4] [5] [6] [7] [8] [9] . In particular, we demonstrated in preceding publications that treatment with cadmium chloride induced apoptosis in U937 human promonocytic cells, but the mode of death was switched to necrosis if the treatment was applied under glutathione depletion conditions [7, 10] . In addition, the efficacy of apoptosis was conditioned by the occurrence of the stress (bheat-shockQ) response, which, as manifested by HSF1 (bheat-shock factor 1Q) activation and HSP70 expression, is also elicited by cadmium ions in this and other myeloid cell types [11, 12] . The phenotypic characteristics of both apoptosis and necrosis are in general well defined, but the mechanisms that regulate cell death are less known.
One of the most relevant aspects in the regulation of apoptosis is the signalling by protein kinases. Serine/ threonine kinases represent a broad category of kinases, which include, among others, the mitogen-activated protein kinases (MAPKs) and the calcium-dependent protein kinases (PKCs) [13] . The PKC family itself includes several isoforms, classified as (i) calciumdependent, or classical PKCs (cPKCs: a, h1, h2, and g), which are activated by diacylglicerol (DAG) or 12-Otetradecanoylphorbol-13-acetate (TPA); (ii) calcium-independent, or novel PKCs (nPKCs: y, e, D, and u), which are activated by DAG or TPA; and (iii) atypical PKCs (aPKCs: j;~and E), which are calcium-independent and are not activated by DAG or TPA [14] . These isozymes present important differences in their enzymatic properties, cell type expression, substrate selectivity, and subcellular localization [15] . Different mechanisms of PKC activation have been described, including translocation to plasma membrane, nucleus or mitochondria, proteolysis, and tyrosine phosphorylation [16] [17] [18] .
The capacity of cadmium ions to cause PKC activation, and the involvement of PCK on cadmium-induced apoptosis, was earlier studied with noncoincident results. For instance, while cadmium ions activated PKC, which in turn seemed to mediate apoptosis induction in lung epithelial cells [19] , the heavy metal did not activate PKC in rat mesangial cells [20] ; and cadmium-induced apoptosis was apparently independent of PCK activation in rat glioma cells [9] . In the present work, we analyze the possible role of PKCy on apoptosis induction by the cadmium chloride in U937 promonocytic cells. The results indicate that cadmium ions cause an early PKCy translocation to membrane fraction, and a late PKCy cleavage and phosphorylation on tyrosine residues, which may be important for apoptosis. In addition, PKCy activation seems to be mediated by the prior activation of p38 MAPK .
Materials and methods

Materials
All components for cell culture were obtained from Invitrogen, Inc. (Carlsbad, CA, USA). Cadmium chloride, TPA, genistein, propidium iodide (PI), and mouse anti-chicken h-tubulin monoclonal antibody were obtained from Sigma (Madrid, Spain). 4,6-Diamino-2phenylindole (DAPI) was obtained from Serva (Heidelberg, Germany); and rottlerin, SB203580 and mouse anti-phosphotyrosine monoclonal antibody (PY20), from Calbiochem (Darmstadt, Germany). All anti-PKC antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Rabbit anti-human p38 MAPK and rabbit antihuman phospho-p38 MAPK (Thr180/Tyr182) polyclonal antibodies were from Cell Signalling Technology (Beverly, MA, USA); mouse anti-human HSP70 monoclonal antibody (clone C92F34-5) from StressGen Biotechnologies Corp. (Victoria, Canada); and goat anti-rabbit and anti-mouse peroxidase-conjugated antibodies from DAKO Diagnostics, S.A. (Barcelona, Spain).
Cells and treatments
Human U937 myeloid leukemia cells [21] were grown in RPMI 1640 medium supplemented with 10% heatinactivated calf serum and 0.2% sodium bicarbonate and antibiotics in a humidified 5% CO 2 atmosphere at 37 8C. Cadmium chloride was prepared in distilled water at 50 mM just before application. TPA, rottlerin, SB203580 and genistein were dissolved in dimethyl sulfoxide at 1.6, 10, 13.2 and 30 mM, respectively, and stored at À20 8C. For cadmium treatments, the cells were incubated for the desired time periods with 200 AM cadmium chloride; and for heat shock, the cells were placed in a bath at 42 8C for the desired time periods. Then, the cells were washed twice with prewarmed RPMI medium, and allowed to recover under standard culture conditions in the absence of the drug. For PKC translocation studies, cells were used immediately after cadmium ion treatment. As control, cells were subjected to the same manipulations as treated cells, at 37 8C and without the drug.
Determination of apoptosis and necrosis
Distinctive characteristics of apoptotic cells were the presence of chromatin condensation/fragmentation and the acquisition of sub-G 1 DNA content. To analyze changes in chromatin structure, the cells were collected by centrifugation, washed with phosphate-buffered saline (PBS), resuspended in PBS, and mounted on glass slides. After fixation in 70% (v/v) ethanol, the cells were stained for 20 min at room temperature with 1 Ag/ml DAPI and examined by fluorescence microscopy. To measure sub-G 1 DNA content, cells were collected by centrifugation and incubated for 30 min in PBS containing 0.5 mg/ml RNase A. After the addition of 50 Ag/ml PI and permeabilization with 0.1% (w/v) Nonidet P-40, the cells were analyzed by flow cytometry. Within the experimental time periods used here necrotic cells did not exhibit sub-G 1 PI incorporation. On the other hand, cells undergoing typical bprimaryQ necrosis exhibited marked swelling and loss of plasma membrane integrity, as evidenced by permeability to trypan blue (by microscopy) or by massive influx of PI in nonpermeabilized cells (by flow cytometry).
Cell lysis and subcellular fractionation
The whole procedure was carried out at 4 8C, and all used media were supplemented with 1% (v/v) 2-mercaptoethanol, 0.1 mM sodium metavanadate, 20 mM sodium fluoride, 10 mg/ml leupeptin and 1 mM phenylmethylsulfonyl fluoride, immediately before use. After washing three time times with cold PBS, the cells were resuspended in a buffer containing 20 mM Tris-HCl, pH 7.5, 5 mM MgSO 4 , and 0.5 mM EGTA, and lysed with 50 strokes of a Dounce homogenizer using a B-type pestle. Complete cell lysis was confirmed by microscopy. When the total lysate had to be directly used for immunoblot assays, the lysis was completed by sonication. Otherwise, the lysate was centrifuged at 800Âg for 10 min. The pellet was used to isolate nuclei. The supernatant was used to isolate cytosolic and membrane fractions, as described below.
The nuclei were obtained by the method of Fields et al. [22] . Briefly, the 800Âg pellet was resuspended in STM buffer (50 mM Tris-HCl, pH 7.4, 250 mM sucrose and 5 mM MgSO 4 ) and capped over a buffer containing 2.1 M sucrose, 50 mM Tris-HCl, pH 7.4, 5 mM MgSO 4 , and 1% v/v 2-mercaptoethanol. Nuclei were successively pelleted at 70,000Âg for 60 min in a SW 28 rotor. Purified nuclei were resuspended in STM buffer and incubated for 60 min with DNase I and RNase A (100 Ag/ml each). Nuclease-treated nuclei were sedimented at 800Âg for 10 min and resuspended in 50 mM Tris-HCl, pH 7.4, at 5Â10 8 nuclei/ml.
The 800Âg supernatant was centrifuged at 100,000Âg for 60 min, and the supernatant collected was used as the cytosolic fraction as described previously [16] . The pellet was resuspended in buffer containing 50 mM Tris-HCl, pH 7.4, 0.5 mM EDTA, 0.5 mM EGTA and 1% nonidet P-40, shaked for 60 min, and centrifuged at 100,000Âg for 60 min. The resulting supernatant was used as the membrane fraction. Marker enzymes were used in conjunction with electron microscopy to ensure the purity of fraction as described previously [23] .
Immunoblot and immunoprecipitation analysis
Immunoblot analysis was basically carried out as previously described [18] . Equal amounts of protein (100 Ag, as determined by the Bradford's method [24] ) from the total extract or from each individual fraction were electrophoresed on 8% SDS-polyacrylamide gels and then transferred to nitrocellulose membranes. After blocking the nonspecific sites with TBS-T solution [0.1% (v/v) Tween 20 in 20 mM Tris base, 137 mM NaCl, pH 7.6] containing 1% (w/v) BSA for 3 h at room temperature, the membranes were incubated with the primary antibody overnight at 4 8C. The membranes were then washed three times (10 min each) in TBS-T solution, and incubated for 2 h at room temperature with horseradish peroxidase-linked secondary antibody (1/1000 dilution in TBS-T solution containing 4% skimmed milk). After washing four times (10 min each) in TBS-T solution, the bound antibody was detected by enhanced chemiluminescence method according to the manufacturer's (Amersham, Uppsala, Sweden) instructions. The scanned images of autoradiograms were quantified using the Sigmagel image program.
Immunoprecipitation of PKCy was performed as described previously [25] . Briefly, after treatment, U-937 cells (10 7 ) were washed with phosphate-buffered saline and then harvested in 600 Al of immunoprecipitation buffer containing 25 mM HEPES, pH 7.2, 10% glycerol, 1 mM EDTA, 1 mM EGTA, 50 mM KCl, 1% Triton X-100, 0.1% SDS, 10 mM NaF, 10 mM Na 4 P 2 O 7 , 1.2 mM Na 3 VO 4 , 2.5 Ag/ml aprotinin, 2.5 Ag/ml pepstatin, 2.5 Ag/ml leupeptin and 1 mM phenylmethanesulfonyl fluoride. The cell suspension was sonicated and then centrifuged at 120,000Âg for 30 min. The supernatant was incubated with 4 Ag anti-PKCy antibody and 20 Al of protein A agarose beads at 4 8C overnight. The immunoprecipitates were washed twice with lysis buffer and then analyzed by Western blotting with anti-phophotyrosine antibody (PY20) as described above. As control, the membranes were routinely reproved using an anti-h tubulin antibody. Fig. 1 shows the capacity of cadmium chloride to cause cell death in U937 cells. The experimental design (pulse-treatment followed by recovery), as well as the cadmium chloride concentration (200 AM), were directly adopted from our earlier studies [10, 26] . It was observed that the treatment provoked a significant apoptosis (about 50% after 120 min of treatment and 6 h recovery), as manifested by the appearance of cells with condensed/ fragmented chromatin ( Fig. 1 ) and the acquisition of sub-G 1 DNA content (results not shown). The frequency of apoptosis depended on the length of both the treatment ( Fig. 1A) and recovery ( Fig. 1B) periods. Other apoptotic markers, as well as caspase activation and the effect of caspase inhibitors, were already examined in preceding works [7, 26] , and hence are omitted here. Under the used conditions, the frequency of necrotic cells remained negligible (approximately 4%, as in untreated cultures).
Results
Apoptosis induction
PKCy translocation, cleavage, phosphorylation on tyrosine residues, and effect of PKC inhibitor
One of the possible manifestations of PKC activation is kinase redistribution between the cytosol and other intracellular compartments [16, 18, 27] . For these reason, immunoblot assays using specific antibodies against different PKC isoforms were carried out to determine possible changes in intracellular PCK localization in cadmiumtreated cells. Among the different PKC isoforms, only PKCa, hI, y, and~were readily detectable in U937 cells (Fig. 2, and results not shown). It was observed that cadmium ions elicited a significant translocation of PKCy from cytosol to the membrane fraction, in a similar manner as TPA (here used as a control), while the redistribution of the other isoforms remained unaltered upon cadmium chloride treatment ( Fig. 2A) . PKCy translocation in response to cadmium chloride was already detected at 30 min of treatment, hence preceding the execution of apoptosis, and was maintained for at least 120 min (Fig.  2B ). On the other hand, cadmium ions did not cause significant translocation of PKC isoforms to nuclei fraction, which, at least in the case of PKCy, is provoked by TPA ( Fig. 2B) .
To examine the possible cause-effect relationship between PKCy translocation to membrane fraction and apoptosis induction, experiments were carried out using rottlerin, which is known to preferentially inhibit this PKC isoform [28] . It was observed that rottlerin prevented PKCy translocation, reaching the maximum effect at the concentration of 10 AM (Fig. 3A) . At this concentration, the inhibitor partially prevented the execution of apoptosis ( Fig. 3B ), indicating that PKCy activation/translocation in fact mediates death induction by cadmium ions. At the assayed conditions, treatment with rottlerin alone did not cause PKCy intracellular redistribution nor apoptosis (results not shown).
Cells treated with apoptosis-inducing agents undergo proteolytic PKCy cleavage, to give a catalytically active fragment that may contribute to apoptosis [29] . For this reason, we wanted to measure PKCy cleavage in response to cadmium chloride treatment, with and without rottlerin. Immunoblot assays indicated that cadmium ions elicited the appearance of the characteristic apoptosis-associated 41-kDa fragment, the amount of which was reduced by rottlerin ( Fig. 4 ). This fragment was detected at 3-6 h of recovery after treatment, concomitantly with the execution of apoptosis (see Fig. 1B ) and the activation of caspase-3 [7] . Treatment with rottlerin alone did not cause the appearance of PKCy-derived 41-kDa fragment (results not shown). This is congruent with the common consideration of PKCy cleavage as a late event, mediated by executioner caspase-3 activity [17] . No apparent cleavage was detected in a, hI, and~isoforms under these conditions of treatment (results not shown). Of note, immunoblot assays using an anti-phosphotyrosine antibody revealed a prominent band of approximately 41 kDa, the intensity of which was increased during the recovery period, and which was reduced by rottlerin ( Fig. 5A) . Moreover, we observed that the specific tyrosine kinase inhibitor genistein decreased the frequency of cadmium-induced apoptosis (Fig. 5B) . At the assayed conditions, apoptosis was not affected by the treatment with genistein alone (data not shown). This findings may be congruent with earlier observations indicating that tyrosine phosphorylation of PKCy influences its catalytic and pro-apoptotic activity [17, 30] . To further analyze the effect of cadmium ions on tyrosine phosphorylation of PKCy, extracts were obtained from cells at 6 h of recovery after cadmium chloride treatment, PKCy was immunoprecipitated with an anti-PKCy antibody, and the membrane was blotted with anti-phosphotyrosine antibody (PY20). As illustrated in Fig. 5C , the PKCy-derived 41-kDa fragment resulted phosphorylated by the treatment, in agreement with the results showed in Fig. 5A .
It has been indicated that rottlerin inhibits cadmium uptake in some cell types [31] . For this reason, we found it of interest to analyze the action of the kinase inhibitor on another well-known effect of cadmium, namely the induction of the stress (bheat-shockQ) response [12, 26] . We observed that rottlerin did not affect the cadmium-elicited increase in HSP70 expression ( Fig. 6A) , ruling out the possibility that the decreased toxicity could be a trivial consequence of transport inhibition or other mechanism of cadmium inactivation [31] . Rottlerin alone did not affect HSP70 expression (results not shown). In addition, to exclude the possibility of a general, nonspecific inhibition of the apoptotic machinery by rottlerin, unrelated to its action as kinase inhibitor, U937 cells were subjected to heatshock treatment. It was observed that heat shock did not cause PKCy translocation, and in agreement with this rottlerin did not affect the heat-provoked apoptosis (Fig.  6B ). Taken together, these results indicate that the attenu-ation of cadmium-provoked apoptosis by rottlerin was a highly specific effect.
p38 MAPK activation
We have previously reported that cadmium ions cause a rapid activation of p38 MAPK , which mediate apoptosis induction in U937 cells [7] . In agreement with this, in the present experiments, we detected an increase in p38 MAPK phosphorylation at 30 min of cadmium chloride treatment (Fig. 7A) , which coincides with the timing of PKCy translocation (see Fig. 2B ). In order to study the possible cause-effect relationship between PKCy and p38 MAPK activation, experiments were carried out using rottlerin and SB203580, a specific inhibitor of p38 MAPK . It was observed that rottlerin did not affect the basal level of p38 MAPK phosphorylation (results not shown) nor the increase in phosphorylation elicited by cadmium ions (Fig.  7B ). By contrast, SB203580 decreased the amount of PKCy detected in membrane fraction (Fig. 7C ), indicating that in our experimental model p38 MAPK precedes and regulates the early PKCy translocation. In addition, SB203580 greatly reduced PKCy cleavage (Fig. 7D) , reduced tyrosine phosphorylation of the 41-kDa fragment (Fig. 7E) , and attenuated apoptosis (Fig. 7F ). SB203580 alone did not affect the PKCy distribution/cleavage nor apoptosis (results not shown).
Discussion
PKC activities have been demonstrated to regulate important cellular functions, such as proliferation, differentiation, and apoptosis [32, 33] . Nevertheless, the effect PKC activation on these processes is not always consistent. Thus, the observation that TPA and other general PKC activators may either prevent [34] [35] [36] [37] [38] or potentiate [36, 37, 39, 40] cell death indicates that PKC may exert both anti-and proapoptotic effects, depending on the cell model and experimental conditions. When specific PKC isoforms are considered, PKC~and E activities have been shown to protect against apoptosis, and PKCa and y activities to mediate apoptosis induction, in multiple cell types [38] [39] [40] . The involvement of PKCy in apoptosis is currently examined using rottlerin, a drug that preferentially inhibits this particular isotype, but the results must be considered with caution because of the possible collateral effects of pharmacological inhibitors. For instance, Blass et al. [30] reported that rottlerin attenuated the cytotoxic action of cadmium ions in CHO cells, but this effect was attributed to the capacity of the drug to inhibit metal uptake in this particular cell line. In the present work, we observed that rottlerin attenuates the cadmium-provoked apoptosis in human U937 promonocytic cells. Although metal uptake was not directly examined, the finding that rottlerin did not affect the stress reaction (as measured by HSP70 expression) indicates that the protective Fig. 7 . Relationships between p38 MAPK activation, PKCy activation, and apoptosis, in cadmium-treated cells. Panels A and B show the relative levels of total (p38-tot) and phosphorylated (p38-P) p38 MAPK at the indicated times of treatment with cadmium chloride (A), or at 120 min of treatment with cadmium chloride in the absence or presence of rottlerin (B). Panels C-D show the amount of PKCy in cytosolic and membrane fractions (C), PKCy cleavage (D), tyrosine phosphorylation level of the 41-kDa fragment (E), and frequency of apoptotic cells (F), in untreated cultures and cultures treated for 120 min with cadmium chloride, either in the absence (Cd 2+ ) or the presence (SB+Cd 2+ ) of 10 AM SB203580, and allowed to recover for 6 h. SB203580 was applied 1 h before cadmium chloride. All blots are representative of one of at least two determinations with similar results. The values in F represent the meanFSD of three experiments. effect is not a trivial consequence of transport inhibition or other mode of cadmium ion inactivation (e.g., direct drugmetal interaction).
Several possible mechanisms for PKCy activation have been described, including kinase translocation from cytosol to other cellular compartments, and kinase cleavage by caspase-3 (or a related enzyme) to give a catalytically active fragment [17] . In the present work, we observed that cadmium chloride elicit a rapid translocation of PKCy from cytosol to membrane (particulate) fraction, preceding all manifestations of apoptosis. The importance of translocation for cadmium-provoked apoptosis was proved by the facts that rottlerin inhibited both the cadmiumprovoked kinase translocation and cell death, and that the toxicity of heat shock, which did not cause kinase translocation, was not affected by rottlerin. On the other hand, cadmium ions apparently failed to cause PKCy increase in the nuclear fraction, which nevertheless was identified as possible target of translocation by other agents [27, 41] . In addition, we observed a late PKCy cleavage to give the typical apoptosis-associated 41-kDa fragment, the amount of which was also reduced by rottlerin. Nevertheless, due to the strict temporal coincidence of this event with the expression of apoptotic markers, we may not clearly discriminate whether PKCy cleavage is a mere consequence of apoptosis or it also plays a regulatory role, as proposed by some authors [20] . Finally, we observed that cadmium ions induced phosphorylation on tyrosine residues in the 41-kDa fragment obtained by proteolytic PKCy cleavage, and that genistein reduced the cadmium-provoked apoptosis. This may be of interest in the framework of the present investigation, since tyrosine phosphorylation has been described as a mechanism that modulates (either enhancing or decreasing) the catalytic and pro-apoptotic activity of PKCy.
Although clearly distinguishable, there are multiple evidences of cross-talk between PKC and MAPK pathways. We were interested in investigating the possible relationship between PCKy and p38 MAPK because this latter kinase seems to be particularly important for the regulation of apoptosis in U937 [7] and other cell models [42] . Actually, several proofs of a link between these kinase activities in relation to apoptosis have been offered, with the frequent observation that PKCy precedes and regulates p38 MAPK [43] . Our results confirm the existence of cause-effect relationship between these kinases in cadmium-treated promonocytic cells, but in our experiments p38 MAPK seems to be upstream PKCy activation. Whether this is a particularity of the experimental model (cell type and/or apoptosis inducer), or it may acquire a more general value, remains to be determined.
